News Overview Diversity & Sustainability News SearchSortNewestOldestA-ZZ-ASort NewestOldestA-ZZ-APortfolioAorticCardiacPeripheralPortfolio AorticCardiacPeripheral 25 Results 06/2023 GORE ANNOUNCES FIRST U.S. ENROLLMENT FOR THE GORE® VIAFORT VASCULAR STENT ILIOFEMORAL STUDY FIRST U.S. PATIENT ENROLLED IN GORE® VIAFORT VASCULAR STENT ILIOFEMORAL PIVOTAL STUDYSee more 03/2023 GORE ANNOUNCES FIRST U.S. ENROLLMENT FOR THE GORE® VIAFORT VASCULAR STENT IVC STUDY First U.S. patient enrolled in GORE® VIAFORT Vascular Stent pivotal study.See more 11/2022 GORE INITIATES THE RELIEF CLINICAL STUDY EVALUATING PFO CLOSURE FOR MIGRAINE HEADACHE RELIEF The Gore RELIEF study is evaluating the safety and efficacy of transcatheter closure of patent...See more 10/2022 Gore Completes First In-human Implants of the GORE® VIAFORT Vascular Stent FLAGSTAFF, Ariz. (October 28, 2022) — W. L. Gore & Associates (Gore) today announced the first...See more 08/2022 GORE ACQUIRES INNAVASC MEDICAL, INC. Gore, a global material science company dedicated to transforming industries and improving...See more 04/2022 GORE MEDICAL RECEIVES BREAKTHROUGH DEVICE DESIGNATION FOR THE GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS FLAGSTAFF, Ariz. (APRIL 12, 2022) — Gore Medical has received Breakthrough Device designation...See more 01/2022 GORE® CARDIOFORM SEPTAL OCCLUDER MARKS 10 YEARS OF IMPROVING LIVES FLAGSTAFF, Ariz. (JAN. 19, 2022) — W. L. Gore & Associates (Gore) today announced that the GORE®...See more 08/2021 FIVE-YEAR RESULTS OF THE GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS PIVOTAL U.S. MULTICENTER STUDY CONFIRM SAFETY, EFFICACY AND DURABILITY FLAGSTAFF, Ariz. (August 19, 2021) — W. L. Gore & Associates (Gore), today announced that...See more 03/2021 GORE REDUCE CLINICAL STUDY FIVE-YEAR RESULTS DEMONSTRATE THAT PFO CLOSURE WITH THE GORE® CARDIOFORM SEPTAL OCCLUDER PROVIDES SAFE LONG-TERM REDUCTION OF RECURRENT STROKE FLAGSTAFF, Ariz. (March 11, 2021)— W. L. Gore & Associates (Gore), today announced that Gore...See more 11/2020 W. L. GORE & ASSOCIATES ANNOUNCES ENCOURAGING SIX-MONTH RESULTS WITH ITS NOVEL BIOSYNTHETIC TISSUE VALVE FLAGSTAFF, Ariz. (November 18, 2020) — W. L. Gore & Associates, Inc. (Gore), a global leader in...See more Load More Media Contacts Jessica MoranArizona, United States+1 480 601 4799jmoran@wlgore.comHenrietta BryanUnited Kingdom+44 (0) 7867 90 6287hbryan@wlgore.com Top
06/2023 GORE ANNOUNCES FIRST U.S. ENROLLMENT FOR THE GORE® VIAFORT VASCULAR STENT ILIOFEMORAL STUDY FIRST U.S. PATIENT ENROLLED IN GORE® VIAFORT VASCULAR STENT ILIOFEMORAL PIVOTAL STUDYSee more
03/2023 GORE ANNOUNCES FIRST U.S. ENROLLMENT FOR THE GORE® VIAFORT VASCULAR STENT IVC STUDY First U.S. patient enrolled in GORE® VIAFORT Vascular Stent pivotal study.See more
11/2022 GORE INITIATES THE RELIEF CLINICAL STUDY EVALUATING PFO CLOSURE FOR MIGRAINE HEADACHE RELIEF The Gore RELIEF study is evaluating the safety and efficacy of transcatheter closure of patent...See more
10/2022 Gore Completes First In-human Implants of the GORE® VIAFORT Vascular Stent FLAGSTAFF, Ariz. (October 28, 2022) — W. L. Gore & Associates (Gore) today announced the first...See more
08/2022 GORE ACQUIRES INNAVASC MEDICAL, INC. Gore, a global material science company dedicated to transforming industries and improving...See more
04/2022 GORE MEDICAL RECEIVES BREAKTHROUGH DEVICE DESIGNATION FOR THE GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS FLAGSTAFF, Ariz. (APRIL 12, 2022) — Gore Medical has received Breakthrough Device designation...See more
01/2022 GORE® CARDIOFORM SEPTAL OCCLUDER MARKS 10 YEARS OF IMPROVING LIVES FLAGSTAFF, Ariz. (JAN. 19, 2022) — W. L. Gore & Associates (Gore) today announced that the GORE®...See more
08/2021 FIVE-YEAR RESULTS OF THE GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS PIVOTAL U.S. MULTICENTER STUDY CONFIRM SAFETY, EFFICACY AND DURABILITY FLAGSTAFF, Ariz. (August 19, 2021) — W. L. Gore & Associates (Gore), today announced that...See more
03/2021 GORE REDUCE CLINICAL STUDY FIVE-YEAR RESULTS DEMONSTRATE THAT PFO CLOSURE WITH THE GORE® CARDIOFORM SEPTAL OCCLUDER PROVIDES SAFE LONG-TERM REDUCTION OF RECURRENT STROKE FLAGSTAFF, Ariz. (March 11, 2021)— W. L. Gore & Associates (Gore), today announced that Gore...See more
11/2020 W. L. GORE & ASSOCIATES ANNOUNCES ENCOURAGING SIX-MONTH RESULTS WITH ITS NOVEL BIOSYNTHETIC TISSUE VALVE FLAGSTAFF, Ariz. (November 18, 2020) — W. L. Gore & Associates, Inc. (Gore), a global leader in...See more